Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients

Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist prescribed to diabetic patients for glycaemic control. To understand the impact of liraglutide in the real-world setting, this study analysed its effects in a Portuguese cohort of Type 2 diabetes patients. This was an observationa...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	José Silva-Nunes, Edite Nascimento, Joana Louro, Jorge Dores, Teresa Laginha, Ana Gonçalves-Ferreira, Marta Alves, Selma B. Souto, Nelson Cunha, Elsa Pina, Rui Duarte, João Filipe Raposo
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-11-01
סדרה:	Metabolites
נושאים:	liraglutide real-world evidence type 2 diabetes glycaemic control anthropometric parameters cardiovascular risk factors
גישה מקוונת:	https://www.mdpi.com/2218-1989/12/11/1121
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!